Hybrid Deep Learning for Aquaculture Drug Discovery
AI-Powered Molecular Screening Reduces Drug Development Costs by 38× While Achieving State-of-the-Art Accuracy
CORAL AI combines 3D structural information with evolutionary sequence patterns to predict protein-ligand interactions with unprecedented accuracy, achieving EF₁% = 38.2 and enabling 15-147% better enrichment than competitors.

Roberto Ibanez
Chief Technology Officer
October 2025